{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:37:49Z","timestamp":1790386669995,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1016\/j.bcmd.2005.05.005","type":"journal-article","created":{"date-parts":[[2005,8,25]],"date-time":"2005-08-25T07:30:58Z","timestamp":1124955058000},"page":"259-267","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":106,"title":["Clinical evaluation of chemokine and enzymatic biomarkers of Gaucher disease"],"prefix":"10.1016","volume":"35","author":[{"given":"Patrick B.","family":"Deegan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Teresa","family":"Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"McFarlane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Paul","family":"Schofield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf G.","family":"Boot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes M.F.G.","family":"Aerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy M.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bcmd.2005.05.005_bib1","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/BF00711365","article-title":"Modifying exogenous glucocerebrosidase for effective replacement therapy in Gaucher disease","volume":"17","author":"Brady","year":"1994","journal-title":"J. Inherited Metab. Dis."},{"issue":"1","key":"10.1016\/j.bcmd.2005.05.005_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/bmmb.1994.1026","article-title":"Enzyme replacement therapy for Gaucher disease: critical investigations beyond demonstration of clinical efficacy","volume":"52","author":"Brady","year":"1994","journal-title":"Biochem. Med. Metab. Biol."},{"issue":"1","key":"10.1016\/j.bcmd.2005.05.005_bib3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.7326\/0003-4819-122-1-199501010-00005","article-title":"Enzyme therapy in type 1 Gaucher disease: comparative efficacy of mannose-terminated glucocerebrosidase from natural and recombinant sources","volume":"122","author":"Grabowski","year":"1995","journal-title":"Ann. Intern. Med."},{"issue":"21","key":"10.1016\/j.bcmd.2005.05.005_bib4","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM199105233242104","article-title":"Replacement therapy for inherited enzyme deficiency-macrophage-targeted glucocerebrosidase for Gaucher's disease","volume":"324","author":"Barton","year":"1991","journal-title":"N. Engl. J. Med."},{"issue":"9214","key":"10.1016\/j.bcmd.2005.05.005_bib5","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0140-6736(00)02161-9","article-title":"Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis","volume":"355","author":"Cox","year":"2000","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.bcmd.2005.05.005_bib6","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/clinchem\/13.7.565","article-title":"Enzymatic abnormalities in diseases of sphingolipid metabolism","volume":"13","author":"Brady","year":"1967","journal-title":"Clin. Chem."},{"issue":"4","key":"10.1016\/j.bcmd.2005.05.005_bib7","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0950-3536(97)80033-9","article-title":"Gaucher's disease: clinical features and natural history","volume":"10","author":"Cox","year":"1997","journal-title":"Bailliere's Clin. Haematol."},{"issue":"4","key":"10.1016\/j.bcmd.2005.05.005_bib8","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0950-3536(97)80037-6","article-title":"Gaucher's disease. Pathological features","volume":"10","author":"Pastores","year":"1997","journal-title":"Bailliere's Clin. Haematol."},{"key":"10.1016\/j.bcmd.2005.05.005_bib9","first-page":"3635","article-title":"Gaucher disease","volume":"vol. III","author":"Beutler","year":"2001"},{"issue":"4","key":"10.1016\/j.bcmd.2005.05.005_bib10","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/qjmed\/93.4.237","article-title":"Massive hepatic fibrosis in Gaucher's disease: clinico-pathological and radiological features","volume":"93","author":"Lachmann","year":"2000","journal-title":"QJM"},{"issue":"4","key":"10.1016\/j.bcmd.2005.05.005_bib11","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/qjmed\/hch036","article-title":"Twin pairs showing discordance of phenotype in adult Gaucher's disease","volume":"97","author":"Lachmann","year":"2004","journal-title":"QJM"},{"issue":"4","key":"10.1016\/j.bcmd.2005.05.005_bib12","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0950-3536(97)80034-0","article-title":"Plasma and metabolic abnormalities in Gaucher's disease","volume":"10","author":"Aerts","year":"1997","journal-title":"Bailliere's Clin. Haematol."},{"issue":"8","key":"10.1016\/j.bcmd.2005.05.005_bib13","first-page":"388","article-title":"Gaucher's disease: a disease with chronic stimulation of the immune system","volume":"106","author":"Shoenfeld","year":"1982","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"2","key":"10.1016\/j.bcmd.2005.05.005_bib14","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0002-9343(02)01150-6","article-title":"Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry","volume":"113","author":"Weinreb","year":"2002","journal-title":"Am. J. Med."},{"issue":"4","key":"10.1016\/j.bcmd.2005.05.005_bib15","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0950-3536(97)80041-8","article-title":"Skeletal involvement in Gaucher's disease","volume":"10","author":"Elstein","year":"1997","journal-title":"Bailliere's Clin. Haematol."},{"issue":"2","key":"10.1016\/j.bcmd.2005.05.005_bib16","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1006\/bcmd.1996.0016","article-title":"Effect of low-dose enzyme replacement therapy on bones in Gaucher disease patients with severe skeletal involvement","volume":"22","author":"Elstein","year":"1996","journal-title":"Blood Cells, Mol. Dis."},{"issue":"4","key":"10.1016\/j.bcmd.2005.05.005_bib17","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1006\/bcmd.2000.0310","article-title":"Comparative efficacy of dose regimens in enzyme replacement therapy of type I Gaucher disease","volume":"26","author":"Altarescu","year":"2000","journal-title":"Blood Cells, Mol. Dis."},{"issue":"7","key":"10.1016\/j.bcmd.2005.05.005_bib18","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/qjmed\/91.7.483","article-title":"Low-dose low-frequency imiglucerase as a starting regimen of enzyme replacement therapy for patients with type I Gaucher disease","volume":"91","author":"Elstein","year":"1998","journal-title":"QJM"},{"issue":"21","key":"10.1016\/j.bcmd.2005.05.005_bib19","first-page":"1565","article-title":"Treatment of Gaucher's disease","volume":"328","author":"Hollak","year":"1993","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.bcmd.2005.05.005_bib20","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1182\/blood.V82.4.1107.1107","article-title":"Home treatment with intravenous enzyme replacement therapy for Gaucher disease: an international collaborative study of 33 patients","volume":"82","author":"Zimran","year":"1993","journal-title":"Blood"},{"issue":"303","key":"10.1016\/j.bcmd.2005.05.005_bib21","first-page":"541","article-title":"Successful treatment of bone marrow failure in Gaucher's disease with low-dose modified glucocerebrosidase","volume":"83","author":"Mistry","year":"1992","journal-title":"Q. J. Med."},{"issue":"1433","key":"10.1016\/j.bcmd.2005.05.005_bib22","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1098\/rstb.2003.1273","article-title":"Biochemistry of glycosphingolipid storage disorders: implications for therapeutic intervention","volume":"358","author":"Aerts","year":"2003","journal-title":"Philos. Trans. R. Soc. London, B. Biol. Sci."},{"key":"10.1016\/j.bcmd.2005.05.005_bib23","first-page":"227","article-title":"Elevation of serum acid phosphatatse in Gaucher's disease","volume":"23","author":"Tuchman","year":"1956","journal-title":"J. Mt. Sinai Hosp."},{"issue":"4","key":"10.1016\/j.bcmd.2005.05.005_bib24","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1084\/jem.143.4.975","article-title":"Acid hydrolases in leukocytes and platelets of normal subjects and in patients with Gaucher's and Fabry's disease","volume":"143","author":"Beutler","year":"1976","journal-title":"J. Exp. Med."},{"issue":"26","key":"10.1016\/j.bcmd.2005.05.005_bib25","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1056\/NEJM197606242942609","article-title":"Elevation of serum angiotensin-converting enzyme in Gaucher's disease","volume":"294","author":"Lieberman","year":"1976","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.bcmd.2005.05.005_bib26","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1172\/JCI117084","article-title":"Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease","volume":"93","author":"Hollak","year":"1994","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.bcmd.2005.05.005_bib27","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/mp.55.2.65","article-title":"Acid phosphatases","volume":"55","author":"Bull","year":"2002","journal-title":"Mol. Pathol."},{"issue":"3","key":"10.1016\/j.bcmd.2005.05.005_bib28","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/clinchem\/26.3.371","article-title":"Acid phosphatase in Gaucher's disease","volume":"26","author":"Robinson","year":"1980","journal-title":"Clin. Chem."},{"issue":"4","key":"10.1016\/j.bcmd.2005.05.005_bib29","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1161\/01.HYP.21.4.455","article-title":"The angiotensin I converting enzyme gene and predisposition to high blood pressure","volume":"21","author":"Harrap","year":"1993","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.bcmd.2005.05.005_bib30","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1136\/hrt.82.5.584","article-title":"Non-adherence with ACE inhibitor treatment is common in heart failure and can be detected by routine serum ACE activity assays","volume":"82","author":"Struthers","year":"1999","journal-title":"Heart"},{"issue":"42","key":"10.1016\/j.bcmd.2005.05.005_bib31","doi-asserted-by":"crossref","first-page":"40911","DOI":"10.1074\/jbc.M301804200","article-title":"Transglycosidase activity of chitotriosidase: improved enzymatic assay for the human macrophage chitinase","volume":"278","author":"Aguilera","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"40","key":"10.1016\/j.bcmd.2005.05.005_bib32","doi-asserted-by":"crossref","first-page":"25680","DOI":"10.1074\/jbc.273.40.25680","article-title":"The human chitotriosidase gene. Nature of inherited enzyme deficiency","volume":"273","author":"Boot","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bcmd.2005.05.005_bib33","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.4049\/jimmunol.159.3.1140","article-title":"A novel human CC chemokine PARC that is most homologous to macrophage-inflammatory protein-1 alpha\/LD78 alpha and chemotactic for T lymphocytes, but not for monocytes","volume":"159","author":"Hieshima","year":"1997","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.bcmd.2005.05.005_bib34","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nri978","article-title":"Alternative activation of macrophages","volume":"3","author":"Gordon","year":"2003","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.bcmd.2005.05.005_bib35","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1182\/blood.V96.5.1969","article-title":"Pathologic gene expression in Gaucher disease: up-regulation of cysteine proteinases including osteoclastic cathepsin K","volume":"96","author":"Moran","year":"2000","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bcmd.2005.05.005_bib36","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1182\/blood-2003-05-1612","article-title":"Marked elevation of the chemokine CCL18\/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention","volume":"103","author":"Boot","year":"2004","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.bcmd.2005.05.005_bib37","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00005792-199211000-00002","article-title":"Gaucher disease. Clinical, laboratory, radiologic, and genetic features of 53 patients","volume":"71","author":"Zimran","year":"1992","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"10.1016\/j.bcmd.2005.05.005_bib38","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1023\/A:1025902113005","article-title":"The role of the iminosugar N-butyldeoxynojirimycin (miglustat) in the management of type I (non-neuronopathic) Gaucher disease: a position statement","volume":"26","author":"Cox","year":"2003","journal-title":"J. Inherited Metab. Dis."},{"issue":"3","key":"10.1016\/j.bcmd.2005.05.005_bib39","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1148\/radiology.185.3.1438773","article-title":"Quantitative imaging of Gaucher disease","volume":"185","author":"Rosenthal","year":"1992","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.bcmd.2005.05.005_bib40","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/0003-2697(79)90769-3","article-title":"A continuous spectrophotometric assay for angiotensin converting enzyme","volume":"95","author":"Holmquist","year":"1979","journal-title":"Anal. Biochem."},{"issue":"3","key":"10.1016\/j.bcmd.2005.05.005_bib41","first-page":"273","article-title":"Continuous photometric measurement of prostate acid phosphatase activity","volume":"9","author":"Hillman","year":"1971","journal-title":"Z. Klin. Chem. Klin. Biochem."},{"key":"10.1016\/j.bcmd.2005.05.005_bib42","series-title":"Statistical Adjustment of Data","author":"Deming","year":"1938"},{"key":"10.1016\/j.bcmd.2005.05.005_bib43","series-title":"Studi in Onore del Professore Salvatore Ortu Carboni. Rome, Italy","first-page":"13","article-title":"Il calcolo delle assicurazioni su gruppi di teste","author":"Bonferroni","year":"1935"},{"issue":"9","key":"10.1016\/j.bcmd.2005.05.005_bib44","first-page":"977","article-title":"Chitotriosidase genotype and plasma activity in patients type 1 Gaucher's disease and their relatives (carriers and non carriers)","volume":"86","author":"Giraldo","year":"2001","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.bcmd.2005.05.005_bib45","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0950-3536(97)80042-X","article-title":"A practical approach to diagnosis and management of Gaucher's disease","volume":"10","author":"Mistry","year":"1997","journal-title":"Bailliere's Clin. Haematol."}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979605000677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979605000677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:22:44Z","timestamp":1761049364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979605000677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["S1079979605000677"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2005.05.005","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2005,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical evaluation of chemokine and enzymatic biomarkers of Gaucher disease","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2005.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}